Antinociceptive effects of ceftriaxone in formalin-induced nociception

Drug Dev Res. 2020 Sep;81(6):728-735. doi: 10.1002/ddr.21680. Epub 2020 May 11.

Abstract

Ceftriaxone (CFX) is a β-lactam antibiotic with analgesic properties. However, its role in the formalin-induced nociception remains unknown. The purpose of this study was to investigate the antinociceptive effect of CFX in the 1% formalin test in rats. Formalin induced a typical nociceptive response (flinching behavior) of two phases. Local peripheral pretreatment (20 min) with CFX (400-800 μg/paw) slightly attenuated the flinching behavior in phase 2, but not phase 1. Acute intraperitoneal pretreatment (20 min) also reduced phase 2 of the formalin test. In both cases, CFX induced a dose-dependent antinociception. We also tested the effect of CFX 1 day after its administration and in two schedules of repeated administration. One-day pretreatment with CFX (50-400 mg/kg, ip) induced a dose-dependent antinociceptive effect in formalin-treated rats. Repeated administration (daily during 3 or 7 days) with CFX (50-400 mg/kg, ip) diminished formalin-induced nociception. Results suggest that local or systemic as well as single or repeated administration of CFX reduces formalin-induced nociception.

Keywords: ceftriaxone; glutamate; inflammatory pain.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analgesics / administration & dosage*
  • Animals
  • Anti-Bacterial Agents / administration & dosage*
  • Ceftriaxone / administration & dosage*
  • Drug Administration Schedule
  • Female
  • Formaldehyde
  • Injections, Intraperitoneal
  • Nociception / drug effects*
  • Pain / chemically induced
  • Pain / drug therapy*
  • Rats, Wistar

Substances

  • Analgesics
  • Anti-Bacterial Agents
  • Formaldehyde
  • Ceftriaxone